Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)

Infliximab belongs to the family of tumor necrosis factor (TNF) alpha inhibitors and since its development, it has revolutionized treatment for both rheumatological diseases and inflammatory bowel disease (IBD). In IBD specifically, it has shown to result in symptomatic, endoscopic, and histological...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasir, Syed Alishan, Patel, Ronak, Wojkiewicz, Steven, Scatena, Robyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883057/
https://www.ncbi.nlm.nih.gov/pubmed/36721597
http://dx.doi.org/10.7759/cureus.33064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883057/
https://www.ncbi.nlm.nih.gov/pubmed/36721597
http://dx.doi.org/10.7759/cureus.33064

Ejemplares similares